Arkema (AKE) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
18 Dec, 2025Executive summary
2024 sales reached €9.54–9.5 billion, with EBITDA up 2.1% to €1.53 billion and a 16.1% margin, demonstrating resilience amid weak global demand and regional disparities.
Specialty Materials and Asian markets drove volume growth, while Europe declined and North America was stable.
Major growth projects and acquisitions, including Dow's laminating adhesives and PI Advanced Materials, supported expansion in flexible packaging and electronics.
Adjusted net income was €616 million (€8.23/share); recurring cash flow was €419 million.
Proposed dividend of €3.60/share, up nearly 3%, with a 44% payout ratio.
Financial highlights
Group sales were €9.54–9.5 billion in 2024, stable year-on-year; volumes up 2.4%, price effect -3%.
EBITDA reached €1,532 million (16.1% margin), up 2.1% year-on-year.
Adjusted net income was €616 million; recurring EBIT was €895 million (9.4% margin).
Recurring cash flow was €419 million; free cash flow €358 million, including €61 million non-recurring outflow.
Net debt stood at €3.2–3.24 billion, with a net debt/EBITDA ratio of 2.1x.
Outlook and guidance
2025 EBITDA guidance: €1.53–1.67 billion, with €100 million incremental EBITDA from major Specialty Materials projects.
Recurring cash flow targeted at €600 million in 2025, supported by lower CapEx and working capital discipline.
Demand expected to start soft in 2025, especially in Europe and U.S.; Asia remains dynamic.
Intermediate segment EBITDA expected to decrease due to refrigerant quota reductions.
Macroeconomic uncertainty and weak demand persist, with Q1 2025 expected slightly below prior year.
Latest events from Arkema
- EBITDA dropped but cash flow and cost savings were strong, with Asia and growth markets outperforming.AKE
Q4 202526 Feb 2026 - Q2 2024 EBITDA rose 8.2% on 3.8% sales growth, with guidance raised for the year.AKE
Q2 20242 Feb 2026 - Q3 2024 EBITDA rose 5.4% to €407 million, margin at 17.0%, amid weak demand and tight debt control.AKE
Q3 202416 Jan 2026 - Ambitious growth, innovation, and sustainability drive strong specialty materials performance.AKE
BNPP Exane CEO Conference Presentation13 Jan 2026 - Q3 2024 saw higher sales and EBITDA, with strong specialty materials growth and sustainability focus.AKE
BOFA European Materials Conference 2024 Presentation13 Jan 2026 - Solid Q2 growth and sustainability focus drive higher 2024 EBITDA outlook of €1.53–1.63bn.AKE
Investor presentation13 Jan 2026 - Strong specialty materials growth, resilient margins, and major investments drive future expansion.AKE
Morgan Stanley Chemicals Cannonball Run Field Trip Presentation13 Jan 2026 - EBITDA margin held at 15.2% in Q2 2025, with cost-saving targets doubled for the year.AKE
Q2 202513 Jan 2026 - Sales growth in Asia offset weak Western demand, but profits fell; 2025 outlook stable.AKE
Q1 202518 Nov 2025